94 related articles for article (PubMed ID: 9722396)
21. Differential response in choice reaction time following apomorphine based on prior dopaminergic treatment.
Müller T; Benz S; Börnke C; Przuntek H
Acta Neurol Scand; 2004 May; 109(5):348-54. PubMed ID: 15080862
[TBL] [Abstract][Full Text] [Related]
22. Multiple subcutaneous abscesses and necroses due to apomorphine pump treatment.
Wojtecki L; Südmeyer M; Schnitzler A
Parkinsonism Relat Disord; 2012 Sep; 18(8):1002. PubMed ID: 22560050
[No Abstract] [Full Text] [Related]
23. A personal tragedy.
Brookman H
Elder Care; 1999; 11(1):44-6. PubMed ID: 10542513
[No Abstract] [Full Text] [Related]
24. Apomorphine for the acute treatment of "off" episodes in Parkinson's disease.
Stacy M; Silver D
Parkinsonism Relat Disord; 2008; 14(2):85-92. PubMed ID: 18083605
[TBL] [Abstract][Full Text] [Related]
25. Future delivery systems for apomorphine in patients with Parkinson's disease.
van Laar T; Van der Geest R; Danhof M
Adv Neurol; 1999; 80():535-44. PubMed ID: 10410768
[No Abstract] [Full Text] [Related]
26. [Insulin-induced panniculitis].
Verbenko EV; Kamynina TS; Zlatkina AR; Ezhova MN
Vestn Dermatol Venerol; 1988; (1):63-6. PubMed ID: 3284233
[No Abstract] [Full Text] [Related]
27. Use of apomorphine in Parkinson's disease.
Stocchi F
Neurol Sci; 2008 Dec; 29 Suppl 5():S383-6. PubMed ID: 19381769
[TBL] [Abstract][Full Text] [Related]
28. Post steroid panniculitis.
Saxena AK
Australas J Dermatol; 1986 Dec; 27(3):143. PubMed ID: 3632514
[No Abstract] [Full Text] [Related]
29. Poststeroid panniculitis: a case report.
Silverman RA; Newman AJ; LeVine MJ; Kaplan B
Pediatr Dermatol; 1988 May; 5(2):92-3. PubMed ID: 3412997
[TBL] [Abstract][Full Text] [Related]
30. [Apomorphine for treatment of "off-periods" in Parkinson's disease].
Zoldan J; Merims D; Kuritzky A; Ziv I; Melamed E
Harefuah; 1999 Nov; 137(10):444-6, 512, 511. PubMed ID: 10959339
[TBL] [Abstract][Full Text] [Related]
31. Nitrofurantoin-induced antinuclear antibodies and panniculitis.
Sanford RG; Olmstead PM
Arthritis Rheum; 1987 Sep; 30(9):1076-8. PubMed ID: 3499153
[No Abstract] [Full Text] [Related]
32. [Weber-Christian's syndrome after pantopaque myelography].
Charles P; Ronne K; Kraft M
Ugeskr Laeger; 1975 Jul; 137(27):1540-1. PubMed ID: 1145865
[No Abstract] [Full Text] [Related]
33. "Apraxia of eyelid opening" induced by levodopa therapy and apomorphine in atypical parkinsonism (possible progressive supranuclear palsy): a case report.
Defazio G; De Mari M; De Salvia R; Lamberti P; Giorelli M; Livrea P
Clin Neuropharmacol; 1999; 22(5):292-4. PubMed ID: 10516881
[TBL] [Abstract][Full Text] [Related]
34. Biphasic effect of apomorphine, an anti-parkinsonian drug, on bladder function in rats.
Uchiyama T; Sakakibara R; Yoshiyama M; Yamamoto T; Ito T; Liu Z; Yamaguchi C; Awa Y; Yano HM; Yanagisawa M; Yamanishi T; Hattori T; Kuwabara S
Neuroscience; 2009 Sep; 162(4):1333-8. PubMed ID: 19501134
[TBL] [Abstract][Full Text] [Related]
35. A double-blind, placebo-controlled study of intranasal apomorphine spray as a rescue agent for off-states in Parkinson's disease.
Dewey RB; Maraganore DM; Ahlskog JE; Matsumoto JY
Mov Disord; 1998 Sep; 13(5):782-7. PubMed ID: 9756146
[TBL] [Abstract][Full Text] [Related]
36. Comparison of apomorphine and levodopa infusions in four patients with Parkinson's disease with symptom fluctuations.
Nyholm D; Constantinescu R; Holmberg B; Dizdar N; Askmark H
Acta Neurol Scand; 2009 May; 119(5):345-8. PubMed ID: 18822087
[TBL] [Abstract][Full Text] [Related]
37. Chemotherapy recall reactions.
Stratman EJ
J Am Acad Dermatol; 2002 May; 46(5):797. PubMed ID: 12004329
[No Abstract] [Full Text] [Related]
38. Case number 31: Nodular panniculitis as expression of Munchausen's syndrome (panniculitis artefacta).
Tausche AK; Hänsel S; Tausche K; Unger S; Schröder HE; Pietsch J
Ann Rheum Dis; 2004 Oct; 63(10):1195-6. PubMed ID: 15361370
[No Abstract] [Full Text] [Related]
39. Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: a prospective study using single-dose challenges.
Katzenschlager R; Hughes A; Evans A; Manson AJ; Hoffman M; Swinn L; Watt H; Bhatia K; Quinn N; Lees AJ
Mov Disord; 2005 Feb; 20(2):151-7. PubMed ID: 15390035
[TBL] [Abstract][Full Text] [Related]
40. [Parkinson therapy 2001, especially apomorphine in idiopathic Parkinson syndrome].
Gutknecht C
Praxis (Bern 1994); 2001 Jun; 90(23):1024-34. PubMed ID: 11447722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
